Room-temperature, atmospheric-pressure plasma needle treatment is used to effectively minimize the adenovirus (AdV) infectivity as quantified by the dramatic reduction of its gene expression in HEK 293A primary human embryonic kidney cells studied by green fluorescent protein imaging.
A very large number of serious human and animal diseases such as AIDS, SARS, common cold, human and avian influenza, chickenpox, and several others are caused by viral infections. 1 The infectious agents of these diseases are virus nanoparticles (virions) that contain DNA/RNA strands encased in a capsid protein coat and in some cases also in an outer lipid envelope. 2 The virions are usually transmitted from the infected cases through airborne dissemination or diffusion during nosocomial (occurring in a hospital) transfusion of blood or body liquids. 3 The onset of the viral infection is usually heralded by the entry of the virion's genetic material into the intracellular space followed by the uncontrollable integration with the host DNA and virus replication. 4 Despite decades of research, virion detection, pre-emptive and post-infection anti-viral treatments and immunotherapies remain ineffective and the morbidity and mortality rates due to the associated infections remain high.
This problem has recently escalated because adenovirus (AdV), one of the most common and treatment-resistant pathogens of respiratory, ophthalmic, and enterogastritic diseases, has very recently been identified as a major obstacle on the way towards the next-generation, potentially revolutionary stem cell therapies. [5] [6] [7] Indeed, the risk of life-threatening systemic AdV infections (affecting the entire body and biologically defined by positive adenoviraemia) during hematopoietic stem cell transplantation may exceed 50%, and even higher in cord blood transplant recipients. 8 Since pre-emptive anti-viral treatments are very complicated (e.g., are based on multiple drug infusions and/or adoptive immunotherapy based on transfer of virotoxic, virion-specific T-cells) and ineffective, 7,9 the quest for reliable AdV inactivation methods and infectivity quantification protocols are presently on the agenda of multidisciplinary virology, microbiology, hematology, biochemistry, genetics, and applied physics research.
Here we report on the effective AdV inactivation using low-temperature, atmospheric-pressure proliferation and apoptosis of a range of prokaryotic and eukaryotic cells. [10] [11] [12] [13] [14] [15] However, successful applications of APPs to virus inactivation are mostly limited to bacterial viruses, e.g., bacteriophages, 16 while mammalian viruses such as the AdV, represent a major challenge. 3, 10 In this work, an APP needle discharge driven by direct current (DC) voltage is used to inactivate the envelope-free AdV, with a double-strand DNA, a diameter of 70 -90 nm, and a genome size of approximately 36 kb. The schematic of the APP setup is shown in Fig.1 . The device is driven by a custom-made DC power supply with the variable voltage up to 20 kV. 17 The main part of the device is a syringe needle with the inner diameter of about 0.3 mm. The needle is connected to the power supply through a 130 MΩ resistor, which is used to limit the discharge current to the safe range for a human body. Helium mixed with 1% O 2 is used as working gas mixture and is let through the syringe with a flow rate of 0.5 l/min. In this study, two treatment methods are adopted and their AdV inactivation effects are compared. One can clearly see that the number of infected cells decreases with the plasma treatment time. In other words, the number of active AdV virions is dramatically reduced after the APP exposure. This effect was quantified using the median tissue culture infective dose (TCID50), which is defined as the amount of the pathogenic agent (AdV) that will produce pathological change in 50% of cell cultures inoculated and is calculated using the Karber method. The number of infectious viruses per ml (PFU/ml) was calculated as PFU/ml = 0.69 × TCID50/ml and expressed in plaque forming units/ml, according to standard protocols.
The survival plots of the adenovirus after the plasma treatment with the two treatment methods are shown in Fig. 4 . The titer decreases dramatically with the treatment time, which remarkably agrees with the observable changes in the fluorescence images. For the treatment time of 2 min, the adenovirus titer decreases in almost one order of magnitude without a cap and almost 2 orders of magnitude when the cap is used. In the latter case, more than 99% of the viruses are inactivated within 8 min, which shows the APP ability for the pre-emptive control of AdV infections. The difference in the inactivation efficacy between the two methods is due to the longer lifetime of the reactive oxygen species, which are restrained from diffusion into the surrounding air by the cap surfaces. This phenomenon is quite similar to the previous report on bacterial and fungal inactivation in APPs. 19 To characterize the active species and the gas temperature in the discharge, optical emission spectra (OES) of the APPs are collected using a Princeton Instruments Acton SpectraHub 2500i
spectroscope. The grating of 1200 g/mm and the slit width of 150 µm are used when scanning the optical emission of the plasma in the 200 -800 nm range. On the other hand, when measuring the 6 second positive system of N 2 , the grating of 3600 g/mm and the slit width of 80 µm are used. In this way, one can accurately measure the vibrational and rotational temperatures of the plasma. 20 Figure   5 (a) shows the simulated spectra and the experimental spectra of the N 2 second positive system bands (0-2 transition). As can be seen from the figure, the simulated spectra with a gas temperature of 300 K have a good fit to the measured spectra. Thus, thermal effect in the adenovirus inactivation appears to be rather insignificant. Figures 5 (b) and (c) show the OES of the plasma in the 280 -500 nm and 500 -800 nm ranges, respectively. These spectra clearly show that excited O, OH, N 2 , N 2 + , and He species are present in the plasma. O and OH species have previously been found particularly effective in inactivating microorganisms. 10 These species can enhance permeability or even partially destroy the outer membranes of the microorganisms, which leads to the effective protein denaturation, lipid peroxidation, as well as major changes in the cell cytoplasm and nucleus.
As mentioned above, the adenovirus consists of only a capsid shell and a double-strand DNA. The plasma-generated reactive species thus firstly damage the capsid, which mainly consists of proteins.
After etching away the protein protective layer, the reactive species could directly act on the DNA of the adenovirus thereby destroying the AdV genetic material. This is consistent with the previous report on the APP effects on the plasmid DNA. 21 The specific mechanism of the dramatic reduction of the AdV infectivity is related to either the much reduced ability of the damaged virion to permeate through the cell membrane or the effectiveness of the AdV DNA to interact with the DNA of the host HEK 293A cells, or both factors.
The first effect mostly owes to the plasma-induced damage to the capsid. On the other hand, the second effect is most likely due to the structural damages (e. 
